On March 11, 2022, Douglas A. Roeder, notified Tandem Diabetes Care, Inc. of his decision not to stand for re-election at the Company's 2022 Annual Meeting of Stockholders (the 2022 Annual Meeting). Mr. Roeder has served on the Board since May 2009 and is currently serving as a Class III director with a term that will end concurrent with the 2022 Annual Meeting. The decision by Mr. Roeder not to stand for re-election did not involve a disagreement with the Company on any matter relating to the Company's operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.98 USD | -6.68% |
|
-7.02% | +35.16% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.16% | 2.58B | |
-4.33% | 183B | |
-1.63% | 104B | |
-3.25% | 68.18B | |
+16.54% | 47.14B | |
-10.90% | 43.97B | |
+5.93% | 40.95B | |
+19.87% | 31.05B | |
-6.00% | 24.11B | |
+12.61% | 24.05B |
- Stock Market
- Equities
- TNDM Stock
- News Tandem Diabetes Care, Inc.
- Tandem Diabetes Care, Inc. Announces That Douglas A. Roeder Notified His Decision Not to Stand for Re-Election